Dr. Jose A Gutierrez Jr., M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 473 State Highway 285, Hebbronville, TX 78361 Phone: 956-795-8100 Fax: 956-718-6294 |
News Archive
In what The Washington Post describes as "political flexibility," GOP presidential nominee Mitt Romney touted the state health law he signed while Massachusetts governor as proof of compassion and empathy, while also sharply criticizing the federal health law, which is viewed as President Barack Obama's signature legislative achievement.
Results from the PrefHer (Patient Preference for Subcutaneous (SC) versus Intravenous (IV) Herceptin) trial show that 92% of early HER2-positive breast cancer patients favoured quicker SC administration of Herceptin compared to the standard IV infusion.1 Presented at the St. Gallen Breast Cancer Conference in Switzerland.
There are too many poorly validated models for predicting cardiovascular disease risk in the general population, researchers report in The BMJ.
CytomX, a biotechnology company developing Probody™ therapeutics for the treatment of cancer, today announced the closing of a $70 million Series D financing round. The financing was led by Fidelity Management & Research Company with participation from Casdin Capital, Cormorant Asset Management, Deerfield Management, Perceptive Advisors, Redmile Group, Tekla Healthcare Investors and Tekla Life Sciences Investors, Venrock Healthcare Capital Partners, Wellington Management Company and additional undisclosed investors.
› Verified 8 days ago